Bliss GVS Pharma Ltd.
| BSE: 506197 | Sector: Health care |
| NSE: BLISSGVS | ISIN Code: INE416D01022 |
| BSE 00:00 | 24 Feb | 176.25 |
3.95 (2.29%) |
OPEN
173.90 |
HIGH
183.00 |
LOW
173.10 |
| NSE 00:00 | 24 Feb | 176.25 |
4.10 (2.38%) |
OPEN
173.05 |
HIGH
178.10 |
LOW
173.05 |
| OPEN | 173.90 |
| PREVIOUS CLOSE | 172.30 |
| VOLUME | 443418 |
| 52-Week high | 224.00 |
| 52-Week low | 82.50 |
| P/E | 24.31 |
| Mkt Cap.(Rs cr) | 1,817 |
| Buy Price | 175.60 |
| Buy Qty | 300.00 |
| Sell Price | 176.25 |
| Sell Qty | 168.00 |
Bliss GVS Pharma Ltd. (BLISSGVS) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 862.15 | 6.15 | 0.72 | 13266.48 |
| Cipla | 789.55 | -1.35 | -0.17 | 12659.15 |
| Sun Pharma.Inds. | 602.55 | -1.50 | -0.25 | 12531.93 |
| Dr Reddy's Labs | 4441.50 | -47.60 | -1.06 | 11850.40 |
| Lupin | 1007.60 | -3.00 | -0.30 | 11025.66 |
| Apollo Hospitals | 3058.25 | 60.90 | 2.03 | 9794.50 |
| Glenmark Pharma. | 466.40 | -0.85 | -0.18 | 6712.63 |
| Alkem Lab | 2765.40 | 39.75 | 1.46 | 6677.08 |
| Cadila Health. | 433.90 | 3.50 | 0.81 | 6347.40 |
| Torrent Pharma. | 2476.35 | 50.80 | 2.09 | 6168.44 |
| Divi's Lab. | 3483.10 | 33.80 | 0.98 | 5310.57 |
| Ipca Labs. | 1868.00 | 66.10 | 3.67 | 4337.82 |
| Piramal Enterp. | 1858.80 | 8.10 | 0.44 | 4219.19 |
| Alembic Pharma | 884.70 | -7.95 | -0.89 | 4132.55 |
| Abbott India | 14582.40 | 107.25 | 0.74 | 4093.14 |
| Glaxosmi. Pharma | 1455.30 | 1.75 | 0.12 | 3224.68 |
| Jubilant Pharmo | 755.40 | -0.05 | -0.01 | 3139.90 |
| Sanofi India | 8156.30 | 183.80 | 2.31 | 3070.60 |
| Laurus Labs | 359.80 | -1.35 | -0.37 | 2797.34 |
| Gland Pharma | 2367.10 | -14.20 | -0.60 | 2633.24 |
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
